342 related articles for article (PubMed ID: 7539133)
1. Human anti-idiotypic antibodies induced a humoral and cellular immune response against a colorectal carcinoma-associated antigen in patients.
Fagerberg J; Steinitz M; Wigzell H; Askelöf P; Mellstedt H
Proc Natl Acad Sci U S A; 1995 May; 92(11):4773-7. PubMed ID: 7539133
[TBL] [Abstract][Full Text] [Related]
2. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
Maruyama H; Zaloudik J; Li W; Sperlagh M; Koido T; Somasundaram R; Scheck S; Prewett M; Herlyn D
Cancer Immunol Immunother; 2000 Jun; 49(3):123-32. PubMed ID: 10881691
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of recombinant GA733-2E antigen (CO17-1A, EGP, KS1-4, KSA, Ep-CAM) in gastro-intestinal carcinoma patients.
Staib L; Birebent B; Somasundaram R; Purev E; Braumüller H; Leeser C; Küttner N; Li W; Zhu D; Diao J; Wunner W; Speicher D; Beger HG; Song H; Herlyn D
Int J Cancer; 2001 Apr; 92(1):79-87. PubMed ID: 11279610
[TBL] [Abstract][Full Text] [Related]
4. Anti-idiotype and recombinant antigen in immunotherapy of colorectal cancer.
Herlyn D; Somasundaram R; Zaloudik J; Jacob L; Harris D; Kieny MP; Sears H; Mastrangelo M
Cell Biophys; 1994; 24-25():143-53. PubMed ID: 7736518
[TBL] [Abstract][Full Text] [Related]
5. Anti-idiotypic antibody and recombinant antigen vaccines in colorectal cancer patients.
Birebent B; Somasundaram R; Purev E; Li W; Mitchell E; Hoey D; Bloom E; Mastrangelo M; Maguire H; Harris DT; Staib L; Braumuller H; Leeser C; Kuttner N; Beger HG; Herlyn D
Crit Rev Oncol Hematol; 2001; 39(1-2):107-13. PubMed ID: 11418307
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor growth by recombinant vaccinia virus expressing GA733/CO17-1A/EpCAM/KSA/KS1-4 antigen in mice.
Zaloudik J; Li W; Jacob L; Kieny MP; Somasundaram R; Acres B; Song H; Zhang T; Li J; Herlyn D
Cancer Gene Ther; 2002 Apr; 9(4):382-9. PubMed ID: 11960289
[TBL] [Abstract][Full Text] [Related]
7. Immunogenic regions of the GA733-2 tumour-associated antigen recognised by autoantibodies of patients with colorectal carcinoma.
Mosolits S; Steinitz M; Harmenberg U; Ruden U; Eriksson E; Mellstedt H; Fagerberg J
Cancer Immunol Immunother; 2002 Jun; 51(4):209-18. PubMed ID: 12012108
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal anti-idiotypic antibody functionally mimics the human gastrointestinal carcinoma epitope GA733.
Maruyama H; Benden A; Li W; Zaloudik J; Koido T; Taupin JL; Acres B; Somasundaram R; Prewett M; Herlyn D
Int J Cancer; 1996 Feb; 65(4):547-53. PubMed ID: 8621241
[TBL] [Abstract][Full Text] [Related]
9. Anti-idiotypic antibody (ab2) vaccines: coupling of Ab2 BR3E4 to KLH increases humoral and/or cellular immune responses in animals and colorectal cancer patients.
Birebent B; Koido T; Mitchell E; Li W; Somasundaram R; Purev E; Hoey D; Mastrangelo M; Maguire H; Harris DT; Nair S; Cai E; Herlyn D
J Cancer Res Clin Oncol; 2001 Oct; 127 Suppl 2():R27-33. PubMed ID: 11768621
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against the tumour-associated antigen GA733-2 in patients with colorectal carcinoma.
Mosolits S; Harmenberg U; Rudén U; Ohman L; Nilsson B; Wahren B; Fagerberg J; Mellstedt H
Cancer Immunol Immunother; 1999 Feb; 47(6):315-20. PubMed ID: 10203061
[TBL] [Abstract][Full Text] [Related]
11. Tumor regression in monoclonal antibody-treated patients correlates with the presence of anti-idiotype-reactive T lymphocytes.
Fagerberg J; Hjelm AL; Ragnhammar P; Frödin JE; Wigzell H; Mellstedt H
Cancer Res; 1995 May; 55(9):1824-7. PubMed ID: 7728746
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory activity of monoclonal anti-idiotypic antibody to anti-colorectal carcinoma antibody CO17-1A in animals and patients.
Herlyn D; Harris D; Zaloudik J; Sperlagh M; Maruyama H; Jacob L; Kieny MP; Scheck S; Somasundaram R; Hart E
J Immunother Emphasis Tumor Immunol; 1994 May; 15(4):303-11. PubMed ID: 8061902
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer vaccines: antiidiotypic antibody, recombinant protein, and viral vector.
Basak S; Eck S; Gutzmer R; Smith AJ; Birebent B; Purev E; Staib L; Somasundaram R; Zaloudik J; Li W; Jacob L; Mitchell E; Speicher D; Herlyn D
Ann N Y Acad Sci; 2000 Jun; 910():237-52; discussion 252-3. PubMed ID: 10911917
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with Ep-CAM protein or anti-idiotypic antibody induces Th1-biased response against MHC class I- and II-restricted Ep-CAM epitopes in colorectal carcinoma patients.
Mosolits S; Markovic K; Frödin JE; Virving L; Magnusson CG; Steinitz M; Fagerberg J; Mellstedt H
Clin Cancer Res; 2004 Aug; 10(16):5391-402. PubMed ID: 15328177
[TBL] [Abstract][Full Text] [Related]
15. Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). II. Is induction of anti-idiotype reactive T cells (T3) of importance for tumor response to mAb therapy?
Fagerberg J; Frödin JE; Ragnhammar P; Steinitz M; Wigzell H; Mellstedt H
Cancer Immunol Immunother; 1994 Mar; 38(3):149-59. PubMed ID: 8124683
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal anti-idiotypic antibody mimicking the gastrointestinal carcinoma-associated epitope CO17-1A elicits antigen-specific humoral and cellular immune responses in colorectal cancer patients.
Birebent B; Mitchell E; Akis N; Li W; Somasundaram R; Purev E; Hoey D; Mastrangelo M; Maguire H; Harris DT; Nair S; Cai D; Zhang T; Herlyn DM
Vaccine; 2003 Apr; 21(15):1601-12. PubMed ID: 12639481
[TBL] [Abstract][Full Text] [Related]
17. Ga733/EpCAM as a target for passive and active specific immunotherapy in patients with colorectal carcinoma.
Mellstedt H; Fagerberg J; Frödin JE; Hjelm-Skog AL; Liljefors M; Markovic K; Mosolits S; Ragnhammar P
Ann N Y Acad Sci; 2000 Jun; 910():254-61; discussion 261-2. PubMed ID: 10911918
[TBL] [Abstract][Full Text] [Related]
18. Recognition of human colon cancer by T cells transduced with a chimeric receptor gene.
Daly T; Royal RE; Kershaw MH; Treisman J; Wang G; Li W; Herlyn D; Eshhar Z; Hwu P
Cancer Gene Ther; 2000 Feb; 7(2):284-91. PubMed ID: 10770638
[TBL] [Abstract][Full Text] [Related]
19. Patients treated with a monoclonal antibody (ab1) to the colorectal carcinoma antigen 17-1A develop a cellular response (DTH) to the "internal image of the antigen" (ab2).
Mellstedt H; Frödin JE; Biberfeld P; Fagerberg J; Giscombe R; Hernandez A; Masucci G; Li SL; Steinitz M
Int J Cancer; 1991 May; 48(3):344-9. PubMed ID: 2040527
[TBL] [Abstract][Full Text] [Related]
20. Cloned antigens and antiidiotypes.
Herlyn D; Somasundaram R; Zaloudik J; Li W; Jacob L; Harris D; Kieny MP; Ricciardi R; Gonczol E; Sears H
Hybridoma; 1995 Apr; 14(2):159-66. PubMed ID: 7590774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
